Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study

Medicine & Life Sciences

• Biomarkers 46%
• Case-Control Studies 57%
• CD4 Lymphocyte Count 21%
• Circulating MicroRNA 100%
• fibrin fragment D 16%
• HIV Infections 63%
• HIV-1 62%
• Interleukin-6 11%
• Logistic Models 4%
• MicroRNAs 60%
• Morbidity 8%
• Mortality 36%
• Neoplasms 4%
• Population 2%
• Regression Analysis 4%
• Serum 32%
• T-Lymphocytes 13%
• Therapeutics 11%